There is a lot of interest in what is the Next Big Thing in next-generation sequencing. The case can be made that the clinical application of NGS (either targeted sequencing or WES or WGS for cancer genomics) will be that growth driver, but I suspect it will be the next […]
Please consider subscribing to this blog - you'll be notified whenever new posts are published.
Your email address will not be shared or distributed. Thanks!